Search Results - "Rizza, Giovanni Manca"

Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study by Panichi, Vincenzo, Rosati, Alberto, Bigazzi, Roberto, Paoletti, Sabrina, Mantuano, Emanuela, Beati, Sara, Marchetti, Valentina, Bernabini, Giada, Grazi, Giovanni, Rizza, Giovanni Manca, Migliori, Massimiliano, Giusti, Riccardo, Lippi, Alberto, Casani, Aldo, Barsotti, Giuliano, Tetta, Ciro

“…Background. Resistance to erythropoiesis-stimulating agents (ESAs) is often associated with chronic inflammation. Here, we investigated how anaemia, ESA…”
Get full text

Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients by Panichi, Vincenzo, Maggiore, Umberto, Taccola, Daniele, Migliori, Massimiliano, Rizza, Giovanni Manca, Consani, Cristina, Bertini, Alessio, Sposini, Stefano, Perez-Garcia, Rafael, Rindi, Paolo, Palla, Roberto, Tetta, Ciro

“…Background. Despite the well known association between interleukin-6 (IL-6) and cardiovascular mortality, no study has so far verified whether IL-6 adds…”
Get full text

A pharmacoeconomic analysis of phosphate binders cost-effectiveness in the RISCAVID study by Panichi, Vincenzo, Rosati, Alberto, Di Giorgio, Adriana, Scatena, Alessia, Bigazzi, Roberto, Grazi, Giovanni, Migliori, Massimiliano, Paoletti, Sabrina, Manca Rizza, Giovanni, Casani, Aldo, Sgambato, Alessandro, Ruggeri, Matteo

“…A pharmacoeconomic analysis of the RISCAVID database aimed at assessing the cost effectiveness of phosphate binders in preventing CV mortality and morbidity…”
Get more information

A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial by Panichi, Vincenzo, Rosati, Alberto, Paoletti, Sabrina, Ferrandello, Paolo, Migliori, Massimiliano, Beati, Sara, Bernabini, Giada, Daini, Roberto, Casani, Aldo, Angelini, Daniela, Parrini, Manuela, Rossi, Arturo, Petrone, Isabella, Barsotti, Giuliano, Donadio, Carlo, Donati, Giaclì, Grazi, Giovanni, Manca Rizza, Giovanni, Garosi, Guido, Sansoni, Enrico, Braccagni, Beatrice, Sidoti, Antonino, Boracelli, Donella, Biagioli, Marina, Moriconi, Luigi, Finato, Viviana, Mannarino, Antonio, Grimaldi, Cristina, Pansa, Filomena, Imperiali, Patrizio, Mura, Carlo, Bianchi, Stefano, Bigazzi, Roberto

“…Oxidative stress is prevalent in dialysis patients and has been implicated in the pathogenesis of cardiovascular disease and anemia. Vitamin E is a fat-soluble…”
Get more information

Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic kidney disease by Panichi, Vincenzo, Mantuano, Emanuela, Paoletti, Sabrina, Santi, Samuele, Manca Rizza, Giovanni, Cutrupi, Sebastiano, Pizzini, Patrizia, Spoto, Belinda, Tripepi, Giovanni, Zoccali, Carmine

“…The endogenous inhibitor of nitric oxide (NO) synthase, asymmetric dimethylarginine (ADMA), is a strong cardiovascular (CV) risk marker in patients with…”
Get more information

In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients by Panichi, Vincenzo, Paoletti, Sabrina, Mantuano, Emanuela, Manca-Rizza, Giovanni, Filippi, Cristina, Santi, Samuele, Taccola, Daniele, Donadio, Carlo, Tramonti, Gianfranco, Innocenti, Maurizio, Casto, Giuseppe, Consani, Cristina, Sbragia, Giulietta, Franzoni, Ferdinando, Galetta, Fabio, Panicucci, Erica, Barsotti, Giuliano

“…Background. The beneficial effects of statins in reducing cardiovascular events have been attributed predominantly to their lipid-lowering effects, recent…”
Get full text

Interleukin-8 is a powerful prognostic predictor of all-cause and cardiovascular mortality in dialytic patients by Panichi, Vincenzo, Taccola, Daniele, Rizza, Giovanni Manca, Consani, Cristina, Ghiadoni, Lorenzo, Filippi, Cristina, Cristofani, Renza, Panicucci, Erica, Migliori, Massimiliano, Sidoti, Antonino, Biagioli, Marina, Boracelli, Donella, Barsotti, Giuliano, Tetta, Ciro

“…Cohort studies have demonstrated an association between C-reactive protein (CRP) and interleukin-6 (IL-6) and all-cause and cardiovascular mortality in…”
Get more information

Warfarin-induced calciphylaxis-related skin ulceration in patients with end-stage renal disease: case report and literature review by Vallini, Valerio, Andreini, Roberto, Sibilia, Gabriella, Venturini, Luigi, Rizza, Giovanni Manca, Bonadio, Angelo Giovanni, Meini, Simone

“…Calciphylaxis is a rare but highly disabling disease, occurring both in chronic kidney disease (CKD) with renal replacement therapy (RRT) and in normal renal…”
Get full text

Severe hypotension during hemofiltration in an uremic patient with metabolic alkalosis by Panichi, Vincenzo, Rizza, Giovanni Manca, Taccola, Daniele, Consani, Cristina, Barsotti, Giuliano

“…We describe a case of medication induced metabolic alkalosis in a maintenance dialysis patient who developed severe hypotension while undergoing a lactate…”
Get more information

FP759A PHARMACOECONOMIC ANALYSIS OF PHOSPHATE BINDERS COST-EFFECTIVENESS IN THE RISCAVID STUDY by Migliori, Massimiliano, Rosati, Alberto, Di Giorgio, Adriana, Scatena, Alessia, Bigazzi, Roberto, Grazi, Giovanni, Paoletti, Sabrina, Manca Rizza, Giovanni, Casani, Aldo, Panichi, Vincenzo

Get full text

Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs online haemodiafiltration: a cross-over randomized multicentre trial by Panichi, Vincenzo, Manca-Rizza, Giovanni, Paoletti, Sabrina, Taccola, Daniele, Consani, Cristina, Filippi, Cristina, Mantuano, Emanuela, Sidoti, Antonino, Grazi, Giovanni, Antonelli, Alessandro, Angelini, Daniela, Petrone, Isabella, Mura, Carlo, Tolaini, Patricia, Saloi, Franco, Ghezzi, Paolo M., Barsotti, Giuliano, Palla, Roberto

“…Background. HFR [double chamber haemodiafiltration (HDF) with reinfusion of regenerated ultrafiltrate] is a novel dialytic method which combines the processes…”
Get full text

Simvastatin and fluvastatin reduce interleukin-6 and interleukin-8 lipopolysaccharide (LPS) stimulated production by isolated human monocytes from chronic kidney disease patients by Mantuano, Emanuela, Santi, Samuele, Filippi, Cristina, Manca-Rizza, Giovanni, Paoletti, Sabrina, Consani, Cristina, Giovannini, Luca, Tramonti, Gianfranco, Carpi, Angelo, Panichi, Vincenzo

“…Abstract Background Statins reduce lipid levels, inflammation and cardiovascular events in patients with coronary artery disease; CKD patients show increased…”
Get full text

Nutritional status and dietary manipulation in predialysis chronic renal failure patients by Cupisti, Adamasco, D'Alessandro, Claudia, Morelli, Ester, Rizza, Giovanni Manca, Galetta, Fabio, Franzoni, Ferdinando, Barsotti, Giuliano

“…A properly implemented dietary treatment for patients with chronic renal failure (CRF) can correct several metabolic and endocrine disturbances and delay…”
Get more information

Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients by Panichi, Vincenzo, Taccola, Daniele, Rizza, Giovanni Manca, Consani, Cristina, Migliori, Massimiliano, Filippi, Cristina, Paoletti, Sabrina, Sidoti, Antonino, Borracelli, Donella, Panicucci, Erica, Giovannini, Luca

“…The most frequent cause of death in hemodialysis (HD) patients is cardiovascular disease (CVD), and chronic inflammation has been identified as an…”
Get more information

Effect of telmisartan on the proteinuria and circadian blood pressure profile in chronic renal patients by Cupisti, Adamasco, Rizza, Giovanni Manca, D’Alessandro, Claudia, Morelli, Ester, Barsotti, Giuliano

“…Telmisartan is a type 1 angiotensin II (AT 1) receptor blocker, effective and safe in the treatment of arterial hypertension. However, data with respect to…”
Get full text